Solvay Pharmaceuticals Enhances Worldwide Drug Development Efforts With SAS

Overview

Shortening drug development cycles is a primary goal of all pharmaceutical companies. But the need is compounded when companies lack sufficient means for sharing the data used in collaborative research efforts at locations spread around the globe. Such was the case for Solvay Pharmaceuticals, a subsidiary corporation of the worldwide Solvay Group of chemical and pharmaceutical companies headquartered in Brussels, Belgium, but with test facilities in the Netherlands, United States, Germany and Japan. Using SAS Drug Development, Solvay Pharmaceuticals effectively removes geographic boundaries to make information available to anyone who needs it, when they need it.